logo
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us

Home » Clinical Trials Show Lipitor Use Increases Diabetes Risk

Clinical Trials Show Lipitor Use Increases Diabetes Risk

A study conducted by the Journal of the American College of Cardiology in 2011 indicated patients taking Lipitor (atorvastatin) had an increased risk of developing type 2 diabetes mellitus. The study compiled results of three large randomized clinical trials and found throughout all trials that patients taking a higher dosage (80mg) of Lipitor reported higher incidents of the development of type 2 diabetes.

Factors associated with Lipitor use and the development of type 2 diabetes include gender and body mass index. The Centers for Disease Control and Prevention define the body mass index as a number calculated from a person’s height and weight that is used to screen for weight categories that may lead to health problems. The following is a chart provided by the CDC for body mass index and weight status.

BMI

Weight Status

Below 18.5

Underweight

18.5 – 24.9

Normal

25.0 – 29.9

Overweight

30.0 and Above

Obese

 

Numerous clinical trials have been conducted and have indicated that women taking Lipitor–or other statin drugs– who have a body mass index of 25 or less, have an increased risk for developing type 2 diabetes mellitus .

The U.S. Food and Drug Administration (FDA) issued a safety notice in February 2012 requiring a label change for Lipitor and other statin drugs to include an increased risk for the development of type 2 diabetes. This notice was given after the FDA completed a comprehensive review statin drugs along with adverse event reports.

Women who have taken Lipitor and have developed type 2 diabetes have filed complaints against Pfizer, the maker of Lipitor. If you or someone you care about been diagnosed with type 2 diabetes after taking Lipitor, contact us. Our product liability attorneys have litigated thousands of claims against pharmaceutical and medical device companies and can discuss your legal rights and options for obtaining compensation.

Contact Us

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

Former Speedway High School Teacher and Coach Faces Child Seduction Charges

The Marion County Prosecutor has charged Tyler Carmichael, a former teacher at Speedway High School and track .. Read More

SEE ALL ALERTS

In the News

Indiana Legal Services and Indiana State Bar Foundation Receive $90,000 donation from Cohen & Malad, LLP Class Action United Way of Central Indiana’s Center for Working Families Receives $32,000 from Cohen & Malad, LLP Settlement Funds Indianapolis Neighborhood Housing Partnership Receives $32,000 from Cohen & Malad, LLP Settlement Funds
READ OUR NEWS